Paige and Leica Biosystems have expanded their partnership to enhance the use of digital pathology workflows at hospitals and laboratories around the world. Building upon the existing partnership, Leica Biosystems has selected Paige as the preferred provider of software-as-a-service (SaaS) digital pathology image management and viewing software along with diverse embedded AI solutions for its line of Aperio GT 450 digital pathology slide scanners.
Leica Biosystems’ Aperio instrumentation is used in hospitals and laboratories around the world. Under the partnership, a co-branded version of Paige’s Platform will be introduced as the core interface between pathologists and Leica Biosystems hardware. Users of Aperio GT 450 scanners will have access to Paige’s full suite of digital pathology software, including the FullFocus viewer; the AI-powered worklist FullFolio; Paige Prostate Suite, which includes Paige Prostate Detect; Paige Breast Suite; Paige’s suite of biomarker algorithms; and all third-party AI software solutions deployed through Paige.
“Our expanded partnership with Leica Biosystems reflects our unwavering commitment to deliver powerful AI applications to pathologists everywhere,” said Andy Moye PhD, Chief Executive Officer at Paige. “With the widespread reach of Leica Biosystems’ scanners, we look forward to providing a seamless end-to-end solution that makes the transition to digital pathology easier for hospitals and laboratories around the world. The goal of our partnership is to help accelerate the ease of adoption of digital pathology and the efficiency with which pathologists can evaluate patient cases and to provide them with the insights needed to take decisive medical action.”
With a heritage of innovation spanning more than 150 years, Leica Biosystems has offered nine generations of continually improving digital slide scanning technology, realised in compact, user-friendly image capture devices that integrate with pathology workflows and laboratory information systems. Paige’s offerings include novel AI applications together with a powerful platform to easily view and manage whole slide images, putting the power of digital pathology into the hands of pathologists.
“As two global leaders in digital pathology, we have a shared goal of advancing the practice of pathology to improve patient care through innovative hardware and AI-driven software,” said Gustavo Perez, President of Leica Biosystems. “We believe that Paige’s differentiated platform and transformative portfolio of AI technologies will provide a streamlined user experience and help pathologists rapidly transition to digital workflows, enabling them to continue the fight against cancer.”
